WHO ICTRP trial
A clinical trial to evaluate the effects of inhaled nitric oxide gas among…
ISRCTN16806663 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN16806663 |
|---|---|
| Public title | A clinical trial to evaluate the effects of inhaled nitric oxide gas among COVID-19 patients with pneumonia |
| Scientific title | A phase II open-label, randomized, controlled feasibility trial to compare the antiviral activity and clinical efficacy of inhaled nitric oxide gas among COVID-19 patients diagnosed with pneumonia with hypoxic respiratory failure |
| Primary sponsor | Amrita Institute of Medical Sciences and Research Centre |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | India |
| Conditions | Adult COVID-19 pneumonia patients with hypoxic respiratory failure Infections and Infestations COVID-19 (SARS-CoV-2 infection) |
| Interventions | Eligible patients will be randomized into two arms either receiving standard of care only (control arm), or standard of care and inhaled Nitric Oxide (iNO) using a helmet or tight sealing oronasal mask (case arm). iNO will be deluvered as… |
| Registration date | Nov 3, 2021 |
| Target size | 25 |
| Secondary IDs | Nil known;Nil known;Nil known |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: